BioMarin International
Manufacturing · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
CanadaPhone Number
(415) 506-6700Website
www.biomarin.caRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About BioMarin International
BioMarin is a global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions. Founded in 1997, the company translates genetic discoveries into therapies for serious, debilitating challenges in rare diseases. Its commercial portfolio includes products such as Brineura, KUVAN, NAGLAZYME, PALYNZIQ, VIMIZIM, and VOXZOGO. BioMarin serves patients with unmet medical needs through a combination of commercial therapies and a clinical and preclinical pipeline, while providing product support services for clinics and patients via the BioMarin RareConnections program.Explore more
Popular SearchesBioMarin International LtdBioMarinBioMarin Pharmaceutical IncSIC Code 28,283NAICS Code 32,325Show more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is BioMarin International your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if BioMarin International is spiking on competitors!
Funding: Get notified immidiatlly once BioMarin International has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if BioMarin International had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at BioMarin International
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when BioMarin International launches new products
BioMarin International, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on BioMarin International recently announced quarterly report
Check if BioMarin International has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to BioMarin International
Compare insights from companies similar to BioMarin International, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
BioMarin International
<$5M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
BioMarin International is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
BioMarin International is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about BioMarin International.
BioMarin International Tech Stack
A closer look at the technologies used by BioMarin International
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding BioMarin International
Sign Up For FreeTo access detailed company insights
BioMarin is a global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions. Founded in 1997, the company translates genetic discoveries into therapies for serious, debilitating challenges in rare diseases. Its commercial portfolio includes products such as Brineura, KUVAN, NAGLAZYME... Read More
